Wolverine Trading, LLC Supernus Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$24.15 - $31.45 $138,741 - $180,680	-5,745 Reduced 42.92%	7,641 $200,000
Q4 2019 Feb 12, 2020	BUY	$19.93 - $29.13 $46,317 - $67,698	2,324 Added 21.01%	13,386 $312,000
Q2 2019 Aug 20, 2019	SELL	$29.96 - $38.87 $119,810 - $155,441	-3,999 Reduced 26.55%	11,062 $366,000
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $252,689 - $323,784	-7,711 Reduced 33.86%	15,061 $528,000
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $430,834 - $691,654	13,970 Added 158.71%	22,772 $737,000
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $375,845 - $497,753	8,802 New	8,802 $443,000

283

60.5M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.07B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.